MAP2K7 and chordoma: The findings of Hu et al[20,21] highlight that fibroblast growth factor receptor (FGFR)/ methyl ethyl ketone (MEK)/ extracellular signal regulated kinase (ERK)/brachyury pathway coordinately regulates chordoma cell growth and survival and may represent a novel chemotherapeutic target for chordoma.